<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Xifaxan from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Xifaxan news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 11:09:56 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Xifaxan" rel="self" type="application/rss+xml" />

	
<item><title>Summer Street Initiates Coverage of Salix Pharmaceuticals (SLXP) with a Buy</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999788&amp;HITNO=0&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999788&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517651034%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3999788&amp;HITNO=0&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3999788&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2517651034%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Analyst expects FDA to approve Salix drug to treat neurological damage from liver failure</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3965277&amp;HITNO=1&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3965277&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2498467209%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3965277&amp;HITNO=1&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3965277&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2498467209%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>DCExaminer.com:</description></item>
<item><title>Actionable Call Alert : Salix Pharmaceuticals (NASDAQ:SLXP): Top Pick For 2010 - Piper</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3883265&amp;HITNO=2&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3883265&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2455666288%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3883265&amp;HITNO=2&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3883265&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2455666288%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>I Stock Analyst:</description></item>
<item><title>Piper Jaffray Names Salix Pharmaceuticals (SLXP) as Top Small Cap Pick for 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3857663&amp;HITNO=3&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3857663&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2442989114%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3857663&amp;HITNO=3&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3857663&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2442989114%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>UPDATE 1-At least two brokerages up Salix Pharma price target</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3858742&amp;HITNO=4&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3858742&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2443426941%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3858742&amp;HITNO=4&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3858742&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2443426941%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FinanzNachrichten.de:</description></item>
<item><title>Salix Pharmaceuticals up 6.5% on Piper Jaffray Share Pricing (SLX...</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3860698&amp;HITNO=5&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3860698&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2444125023%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3860698&amp;HITNO=5&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3860698&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2444125023%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Zibb:</description></item>
<item><title>STOCKS NEWS US-Salix Pharma gains after brokers up targets</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3859466&amp;HITNO=6&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3859466&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2443654054%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3859466&amp;HITNO=6&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3859466&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2443654054%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FinanzNachrichten.de:</description></item>
<item><title>Salix Pharmaceuticals to Present at Piper Jaffray Conference</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3684630&amp;HITNO=7&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3684630&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2355535997%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3684630&amp;HITNO=7&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3684630&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2355535997%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Salix Pharmaceuticals to Present at Piper Jaffray Conference</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3683975&amp;HITNO=8&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3683975&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2355336587%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3683975&amp;HITNO=8&amp;MSIZE=9&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Xifaxan&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3683975&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2355336587%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Wire via Yahoo!:</description></item>
</channel></rss>